Zdeněk Seidl

3.3k total citations
99 papers, 2.5k citations indexed

About

Zdeněk Seidl is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Zdeněk Seidl has authored 99 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pathology and Forensic Medicine, 27 papers in Neurology and 27 papers in Rheumatology. Recurrent topics in Zdeněk Seidl's work include Multiple Sclerosis Research Studies (44 papers), Systemic Lupus Erythematosus Research (18 papers) and Poisoning and overdose treatments (14 papers). Zdeněk Seidl is often cited by papers focused on Multiple Sclerosis Research Studies (44 papers), Systemic Lupus Erythematosus Research (18 papers) and Poisoning and overdose treatments (14 papers). Zdeněk Seidl collaborates with scholars based in Czechia, United States and Italy. Zdeněk Seidl's co-authors include Manuela Vaněčková, Jan Krásenský, Dana Horáková, Eva Havrdová, Robert Zivadinov, Niels Bergsland, Michaela Týblová, Michael G. Dwyer, Tomáš Kalinčík and Tomáš Uher and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Zdeněk Seidl

95 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zdeněk Seidl Czechia	31	1.5k	665	522	441	362	99	2.5k
Manuela Vaněčková Czechia	33	2.1k 1.3×	911 1.4×	605 1.2×	535 1.2×	387 1.1×	148	3.2k
Lois J. Mannon United States	27	1.2k 0.8×	864 1.3×	382 0.7×	1.0k 2.3×	139 0.4×	31	2.8k
Emilia Sbardella Italy	33	912 0.6×	447 0.7×	206 0.4×	473 1.1×	47 0.1×	101	3.0k
John B. Selhorst United States	26	433 0.3×	1.7k 2.6×	179 0.3×	170 0.4×	418 1.2×	64	3.1k
Masafumi Ogawa Japan	29	533 0.3×	653 1.0×	154 0.3×	365 0.8×	68 0.2×	113	3.4k
Clare L. Fraser Australia	29	651 0.4×	846 1.3×	336 0.6×	282 0.6×	29 0.1×	142	2.7k
Dorothea Buck Germany	25	1.2k 0.8×	443 0.7×	296 0.6×	605 1.4×	16 0.0×	41	2.5k
C. Fieschi Italy	38	809 0.5×	1.8k 2.7×	284 0.5×	587 1.3×	90 0.2×	163	4.5k
Yvonne Naegelin Switzerland	29	2.1k 1.3×	967 1.5×	521 1.0×	477 1.1×	16 0.0×	83	3.5k
Tobias Granberg Sweden	26	750 0.5×	839 1.3×	161 0.3×	648 1.5×	16 0.0×	84	2.2k

Countries citing papers authored by Zdeněk Seidl

Since Specialization

Citations

This map shows the geographic impact of Zdeněk Seidl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Seidl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Seidl more than expected).

Fields of papers citing papers by Zdeněk Seidl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdeněk Seidl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Seidl. The network helps show where Zdeněk Seidl may publish in the future.

Co-authorship network of co-authors of Zdeněk Seidl

This figure shows the co-authorship network connecting the top 25 collaborators of Zdeněk Seidl. A scholar is included among the top collaborators of Zdeněk Seidl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdeněk Seidl. Zdeněk Seidl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horáková, Dana, Tomáš Uher, Jan Krásenský, et al.. (2020). Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study. Multiple Sclerosis and Related Disorders. 46. 102543–102543. 16 indexed citations

Nurieva, Olga, Jaroslav A. Hubáček, Pavel Urban, et al.. (2018). Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study. Clinical Toxicology. 57(6). 387–397. 18 indexed citations

Burgetová, Andrea, Petr Dušek, Manuela Vaněčková, et al.. (2017). Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis. American Journal of Neuroradiology. 38(6). 1079–1086. 33 indexed citations

Uher, Tomáš, Jan Krásenský, Manuela Vaněčková, et al.. (2017). A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long‐Term Comparative Study. Journal of Neuroimaging. 27(6). 620–629. 21 indexed citations

Uher, Tomáš, Eva Havrdová, Lukáš Sobíšek, et al.. (2016). Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?. Multiple Sclerosis Journal. 23(2). 242–252. 34 indexed citations

Smeets, Dirk, Annemie Ribbens, Diana M. Sima, et al.. (2016). Reliable measurements of brain atrophy in individual patients with multiple sclerosis. Brain and Behavior. 6(9). e00518–e00518. 50 indexed citations

Uher, Tomáš, Manuela Vaněčková, Maria Pia Sormani, et al.. (2016). Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach. European Journal of Neurology. 24(2). 292–301. 30 indexed citations

Uher, Tomáš, Dana Horáková, Michaela Týblová, et al.. (2015). Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later. Multiple Sclerosis Journal. 22(6). 770–781. 44 indexed citations

Uher, Tomáš, Ralph H. B. Benedict, Dana Horáková, et al.. (2014). Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment. Journal of the Neurological Sciences. 347(1-2). 229–234. 9 indexed citations

10.

Uher, Tomáš, Dana Horáková, Niels Bergsland, et al.. (2014). MRI correlates of disability progression in patients with CIS over 48 months. NeuroImage Clinical. 6. 312–319. 32 indexed citations

11.

Zakharov, Sergey, Daniela Pelclová, Pavel Urban, et al.. (2014). Czech mass methanol outbreak 2012: Epidemiology, challenges and clinical features. Clinical Toxicology. 52(10). 1013–1024. 110 indexed citations

12.

Kalinčík, Tomáš, Charles R.G. Guttmann, Jan Krásenský, et al.. (2013). Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome. Genes and Immunity. 14(4). 244–248. 17 indexed citations

13.

Seidl, Zdeněk, Josef Vymazal, Marek Mechl, et al.. (2012). Does Higher Gadolinium Concentration Play a Role in the Morphologic Assessment of Brain Tumors? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol versus Gadobenate Dimeglumine (the MERIT Study). American Journal of Neuroradiology. 33(6). 1050–1058. 29 indexed citations

14.

Bergsland, Niels, Dana Horáková, Michael G. Dwyer, et al.. (2012). Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis. American Journal of Neuroradiology. 33(8). 1573–1578. 130 indexed citations

15.

Horáková, Dana, Michal Kýr, Eva Havrdová, et al.. (2010). Apolipoprotein E ε4-Positive Multiple Sclerosis Patients Develop More Gray-Matter and Whole-Brain Atrophy: a 15-Year Disease History Model Based on a 4-Year Longitudinal Study. Folia Biologica. 56(6). 242–251. 7 indexed citations

16.

Roth, Jan, et al.. (2008). Průběh onemocnění moyamoya u pacientky sledované od 3 let do 40 let věku. Neurologie pro praxi. 9(1). 49–51.

17.

Albrechtová, Jana, Zdeněk Seidl, Jacqueline A. Aitkenhead‐Peterson, et al.. (2008). Spectral analysis of coniferous foliage and possible links to soil chemistry: Are spectral chlorophyll indices related to forest floor dissolved organic C and N?. The Science of The Total Environment. 404(2-3). 424–432. 14 indexed citations

18.

Horáková, Dana, Jafna L. Cox, Eva Havrdová, et al.. (2007). Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. Journal of Neurology Neurosurgery & Psychiatry. 79(4). 407–414. 70 indexed citations

19.

Doležal, Ondřej, Michael G. Dwyer, Dana Horáková, et al.. (2007). Detection of Cortical Lesions is Dependent on Choice of Slice Thickness in Patients with Multiple Sclerosis. International review of neurobiology. 79. 475–489. 24 indexed citations

20.

Seidl, Zdeněk, et al.. (2004). The examination of the temporomandibular joint on 1,5T magnetic resonance.. PubMed. 105(1). 29–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact